Vesanoid

   
Google
 
Web NewDrugInformation.com

Vesanoid


Drug - Vesanoid
The trade name of the product as shown on the labeling.

Dosage - CAPSULE; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Tretinoin
Multiple ingredients are in alphabetical order.

Strength - 10MG
The potency of the active ingredient(s), Tretinoin. May repeat for multiple part products.

Applicant - ROCHE
The firm name holding legal responsibility for Vesanoid. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 020438
The FDA assigned number to Vesanoid. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Vesanoid. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Nov 22, 1995
The date Vesanoid was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - Yes
The pioneer or innovator of Vesanoid. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Vesanoid is in. Format is RX, OTC, DISCN.

Applicant Full Name - Hoffmann La Roche Inc
The full name of the firm holding legal responsibility for the new application of Vesanoid.

Vesanoid